Rejoinder

References

• Beal , S. L. and Sheiner , L. B. 1980 . “The NONMEM System,” . The American Statistician , 34 : 118 – 119 .
   Web of Science ®Google Scholar
• Maitre , P. O. , Buhrer , M. , Thomson , D. and Stanski , D. R. 1991 . “A Three-Step Approach Combining Bayesian Regression and NONMEM Population Analysis: Application to Midazolam,” . Journal of Pharmacokinetics and Biopharmaceutics , 19 : 377 – 384 .
   PubMedGoogle Scholar
• Mandema , J. W. “Population PK/PD of Analgesics: Theory and Applications,” . Conference on the Population Approach: Measuring and Managing Variability in Response, Concentration and Dose . Geneva .
   Google Scholar
• Mandema , J. W. and Stanski , D. R. 1996 . “Population Pharmacodynamic Model for Ketorolac Analgesia,” . Clinical Pharmacology and Therapeutics , 60 : 619 – 635 .
   PubMed Web of Science ®Google Scholar
• Mandema , J. W. , Verotta , D. and Sheiner , L. B. 1992 . “Building Population Pharmacokinetic-Pharmacodynamic Models,” . Journal of Pharmacokinetics and Biopharmaceutics , 20 1992
   Google Scholar
• Sheiner , L. B. 1989 . “Clinical Pharmacology and the Choice Between Theory and Empiricism,” . Clinical Pharmacology and Therapeutics , 46 : 605 – 615 .
   PubMed Web of Science ®Google Scholar
• Sheiner , L. B. 1991 . “The Intellectual Health of Clinical Drug Evaluation,” . Clinical Pharmacology and Therapeutics , 50 : 4 – 9 .
   PubMed Web of Science ®Google Scholar
• Sheiner , L. B. 1994 . “A New Approach to the Analysis of Analgesic Drug Trials, Illustrated With Bromfenac Data,” . Clinical Pharmacology and Therapeutics , 56 : 309 – 322 .
   PubMed Web of Science ®Google Scholar
• Sheiner , L. B. 1997 . “Learning vs. Confirming in Clinical Drug Development,” . Clinical Pharmacology and Therapeutics , 61 : 275 – 291 .
   PubMed Web of Science ®Google Scholar
• Sheiner , L. B. and Rubin , D. B. 1995 . “Intention to Treat Analysis and the Goals of Clinical Trials,” . Clinical Pharmacology and Therapeutics , 57 : 6 – 15 .
   PubMed Web of Science ®Google Scholar